Cal earned his Bachelor of Science in Natural Sciences from the University of Pittsburgh in 2017. His undergraduate research with UPMC’s Department of Cardiothoracic Surgery focused on the necessity of postoperative anticoagulation following surgical intervention for atrial fibrillation. Following graduation, Cal joined the Rivella lab’s gene therapy team lead by Dr. Laura Breda. He assisted Dr. Amaliris Gonzalez in investigating novel techniques aimed at improving the sickle cell disease (SCD) and beta-thalassemia phenotype. In the process, Cal learned the fundamental mechanisms that govern differentiation in erythropoiesis. Cal succesfully enrolled in the Medical School at the Thomas Jefferson University.